 | Brokerages Anticipate Relmada Therapeutics, Inc. (NASDAQ:RLMD) Will Post Earnings of -$1.11 Per Share
americanbankingnews.com - January 22 at 12:22 PM |
 | Will 2021 Continue To Be An Exciting Year For Relmada Therapeutics?
nasdaq.com - January 13 at 8:21 AM |
| Relmada Therapeutics (NASDAQ:RLMD) Shares Up 12%
americanbankingnews.com - January 12 at 7:14 PM |
| Relmada Therapeutics, Inc. (OTCMKTS:RLMD) Receives Consensus Recommendation of "Hold" from Analysts
americanbankingnews.com - January 4 at 4:24 AM |
| Zacks: Brokerages Anticipate Relmada Therapeutics, Inc. (NASDAQ:RLMD) to Announce -$0.86 EPS
americanbankingnews.com - December 30 at 3:14 PM |
| Relmada Therapeutics (NASDAQ:RLMD) Trading Down 1.3%
americanbankingnews.com - December 29 at 3:16 AM |
 | Is RLMD A Good Stock To Buy Now?
finance.yahoo.com - December 9 at 4:19 PM |
| Relmada Therapeutics Announces Initiation of Phase 3 Program for REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder
finance.yahoo.com - December 7 at 9:12 AM |
| We Think Relmada Therapeutics (NASDAQ:RLMD) Can Afford To Drive Business Growth
finance.yahoo.com - December 3 at 8:42 AM |
| Relmada Therapeutics to Participate in Upcoming Investor Conferences
finance.yahoo.com - November 17 at 9:27 AM |
|
| Relmada Therapeutics, Inc. Common Stock (RLMD)
nasdaq.com - October 23 at 12:02 AM |
| Oppenheimer: These 2 “Strong Buy” Stocks Are Poised to Surge by Over 80%
finance.yahoo.com - July 17 at 10:41 AM |
| Relmada Therapeutics Announces Uplisting to the Nasdaq Global Select Market®
finance.yahoo.com - July 13 at 1:05 PM |
 | Relmada Therapeutics Inc.
www.marketwatch.com - July 9 at 7:25 PM |
| We're Not Worried About Relmada Therapeutics's (NASDAQ:RLMD) Cash Burn
finance.yahoo.com - June 26 at 8:11 AM |
| Hedge Funds Are Nibbling On Relmada Therapeutics, Inc. (RLMD)
finance.yahoo.com - June 24 at 5:57 PM |
 | BRIEF-Relmada Therapeutics Announces Notice Of Allowance For Patent In Canada
www.reuters.com - June 23 at 10:24 AM |
| Relmada Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
finance.yahoo.com - June 9 at 9:21 AM |
| Relmada Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference
finance.yahoo.com - May 29 at 9:47 AM |
| Relmada Therapeutics Announces Outcome of End-of-Phase 2 Meeting with FDA for REL-1017 for Adjunctive Treatment of Patients with Major Depressive Disorder
finance.yahoo.com - May 27 at 8:08 AM |
| Relmada Therapeutics Appoints Molly Harper as Executive Vice President of Operations
finance.yahoo.com - May 26 at 8:41 AM |
 | SunTrust sees 90% upside in Relmada Therapeutics in premarket analyst action
seekingalpha.com - May 4 at 9:25 AM |
| Relmada Therapeutics Enhances Senior Leadership Team with Appointment of Brian A. Walter, Ph.D., as Vice President of Regulatory Affairs
finance.yahoo.com - April 28 at 11:21 AM |
| Goldman Sachs: 2 Stocks That Could Climb Over 60%
finance.yahoo.com - April 27 at 9:48 AM |
| Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety
finance.yahoo.com - March 31 at 11:18 AM |
| Should You Take Comfort From Insider Transactions At Relmada Therapeutics, Inc. (NASDAQ:RLMD)?
finance.yahoo.com - March 28 at 12:03 PM |
| Relmada Therapeutics Strengthens Scientific Leadership Team with the Appointment of Judy Caron, Ph.D., as Vice President of Drug Development
finance.yahoo.com - March 24 at 9:11 AM |
| Relmada Therapeutics: A Promising Depression Focused Player For 2020
seekingalpha.com - February 17 at 12:37 PM |
 | Relmada Therapeutics Announces $6.9 Million Private Placement
www.bloomberg.com - February 14 at 10:58 PM |
 | 70 Biggest Movers From Yesterday
www.msn.com - December 12 at 11:08 PM |
|
| Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock
finance.yahoo.com - December 10 at 8:40 AM |
| Relmada Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - December 9 at 6:14 PM |
| AUPH Soars On Lupus Trial Results, ACAD On Watch, ALNA Trims Workforce
www.nasdaq.com - December 5 at 12:03 AM |
 | Alexander Capital, L.P. Congratulates Relmada Therapeutics, Inc. on Its $100 Million Financing
www.baystreet.ca - December 4 at 7:03 PM |
| Relmada Therapeutics Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - December 3 at 11:32 PM |
| SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Relmada Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
finance.yahoo.com - November 19 at 5:09 PM |
| Relmada Therapeutics, Inc. Rings the Opening Bell
www.nasdaq.com - October 28 at 5:47 PM |
| Relmada to Ring NASDAQ Stock Market Opening Bell on Friday, October 18
finance.yahoo.com - October 17 at 1:30 PM |
| BRIEF-Relmada Therapeutics Inc Announces Top-Line Results From REL-1017 Phase 2 Study In Individuals With Treatment Resistant Depression
www.msn.com - October 15 at 10:30 PM |
| Relmada Therapeutics Announces Top-Line Results from REL-1017 Phase 2 Study in Individuals with Treatment Resistant Depression
finance.yahoo.com - October 15 at 12:29 PM |
| Relmada Therapeutics stock rockets 137% on positive trial of depression treatment
finance.yahoo.com - October 15 at 12:29 PM |
 | Relmada Therapeutics to Announce Results of Phase...
www.benzinga.com - October 14 at 6:44 PM |
| Relmada Therapeutics Announces Commencement of Trading on The NASDAQ Capital Market
finance.yahoo.com - October 10 at 8:55 AM |
| Relmada Therapeutics announces 1-for-4 reverse stock split for proposed uplisting to NASDAQ
seekingalpha.com - September 27 at 4:40 PM |
| Relmada Therapeutics Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market
finance.yahoo.com - September 27 at 4:40 PM |
| Collision With Reality Sends Abeona Stock Spiraling Lower
seekingalpha.com - July 31 at 10:11 AM |
| Relmada advancing depression candidate REL-1017, mid-stage data readout this quarter
seekingalpha.com - July 29 at 6:44 PM |
| Relmada Therapeutics Announces Completion of Dosing with REL-1017 in Phase 2 Study of Individuals with Treatment Resistant Depression
finance.yahoo.com - July 29 at 8:27 AM |
| Relmada Therapeutics to Present at LD Micro Invitational Conference in Los Angeles
finance.yahoo.com - June 3 at 9:41 AM |
| Relmada Therapeutics Presents Development Program of REL1017 for Treatment of Depression at the 2019 American Society of Clinical Psychopharmacology Meeting
finance.yahoo.com - May 31 at 9:50 AM |
